Article Versions Notes

Michaely LM, Schuwerk L, Allnoch L, Schön K, Waltl I, Larsen P-K, Pavlou A, Prajeeth CK, Rimmelzwaan GF, Becker SC, et al. Intact Type I Interferon Receptor Signaling Prevents Hepatocellular Necrosis but Not Encephalitis in a Dose-Dependent Manner in Rift Valley Fever Virus Infected Mice. International Journal of Molecular Sciences. 2022; 23(20):12492. https://doi.org/10.3390/ijms232012492

Michaely, Lukas Mathias, Lukas Schuwerk, Lisa Allnoch, Kathleen Schön, Inken Waltl, Pia-Katharina Larsen, Andreas Pavlou, Chittappen Kandiyil Prajeeth, Guus F. Rimmelzwaan, Stefanie C. Becker, and et al. 2022. "Intact Type I Interferon Receptor Signaling Prevents Hepatocellular Necrosis but Not Encephalitis in a Dose-Dependent Manner in Rift Valley Fever Virus Infected Mice" International Journal of Molecular Sciences 23, no. 20: 12492. https://doi.org/10.3390/ijms232012492

Michaely, L. M., Schuwerk, L., Allnoch, L., Schön, K., Waltl, I., Larsen, P.-K., Pavlou, A., Prajeeth, C. K., Rimmelzwaan, G. F., Becker, S. C., Kalinke, U., Baumgärtner, W., & Gerhauser, I. (2022). Intact Type I Interferon Receptor Signaling Prevents Hepatocellular Necrosis but Not Encephalitis in a Dose-Dependent Manner in Rift Valley Fever Virus Infected Mice. International Journal of Molecular Sciences, 23(20), 12492. https://doi.org/10.3390/ijms232012492